paper-with-me

Papers

Machine learning for accelerating the discovery of high performance low-cost solar cells: a systematic review

2022-12-26 · Satyam Bhatti, Habib Ullah Manzoor, Bruno Michel, Ruy Sebastian Bonilla, Richard Abrams, Ahmed Zoha, Sajjad Hussain, Rami Ghannam

Solar photovoltaic (PV) technology has merged as an efficient and versatile method for converting the Sun's vast energy into electricity. Innovation in developing new materials and solar cell architectures is required to ensure lightweight, portable, and flexible miniaturized electronic devices operate for long periods with reduced battery demand. Recent advances in biomedical implantable and wearable devices have coincided with a growing interest in efficient energy-harvesting solutions. Such devices primarily rely on rechargeable batteries to satisfy their energy needs. Moreover, Artificial Intelligence (AI) and Machine Learning (ML) techniques are touted as game changers in energy harvesting, especially in solar energy materials. In this article, we systematically review a range of ML techniques for optimizing the performance of low-cost solar cells for miniaturized electronic devices. Our systematic review reveals that these ML techniques can expedite the discovery of new solar cell materials and architectures. In particular, this review covers a broad range of ML techniques targeted at producing low-cost solar cells. Moreover, we present a new method of classifying the literature according to data synthesis, ML algorithms, optimization, and fabrication process. In addition, our review reveals that the Gaussian Process Regression (GPR) ML technique with Bayesian Optimization (BO) enables the design of the most promising low-solar cell architecture. Therefore, our review is a critical evaluation of existing ML techniques and is presented to guide researchers in discovering the next generation of low-cost solar cells using ML techniques.

📄 PDF Abstract BibTeX arXiv:2212.13893

Code (0)

등록된 구현이 없습니다.

Tasks

Bayesian OptimizationGPR

Methods 이 논문이 사용한 방법론

Gaussian Process Gaussian Processes are non-parametric models for approximating functions. They rely upon a measure of similarity between points (the kernel function) to predict the value for…

Similar Papers 제목 키워드 기반

Quantum-machine-assisted Drug Discovery: Survey and Perspective

2024-08-24 · Yidong Zhou, Jintai Chen, Jinglei Cheng, Gopal Karemore 외

Drug discovery and development is a highly complex and costly endeavor, typically requiring over a decade and substantial financial investment to bring a new drug to market. Traditional computer-aided drug design (CADD) …

Drug DesignDrug DiscoverySurvey

Accelerating Antibiotic Discovery with Large Language Models and Knowledge Graphs

2025-03-20 · Maxime Delmas, Magdalena Wysocka, Danilo Gusicuma, André Freitas

The discovery of novel antibiotics is critical to address the growing antimicrobial resistance (AMR). However, pharmaceutical industries face high costs (over $1 billion), long timelines, and a high failure rate, worsene…

Decision MakingKnowledge Graphs

Docking-based Virtual Screening with Multi-Task Learning

2021-11-18 · Zijing Liu, Xianbin Ye, Xiaomin Fang, Fan Wang 외

Machine learning shows great potential in virtual screening for drug discovery. Current efforts on accelerating docking-based virtual screening do not consider using existing data of other previously developed targets. T…

BIG-bench Machine LearningDrug DiscoveryMulti-Task Learning

Artificial Intelligence and Generative Models for Materials Discovery -- A Review

2025-08-05 · Albertus Denny Handoko, Riko I Made arxiv

High throughput experimentation tools, machine learning (ML) methods, and open material databases are radically changing the way new materials are discovered. From the experimentally driven approach in the past, we are m…

SCORCH2: a generalised heterogeneous consensus model for high-enrichment interaction-based virtual screening

2025-04-05 · bioRxiv 2025 4 · Lin Chen, Vincent Blay, Pedro J. Ballester, Douglas R. Houston

The discovery of effective therapeutics remains a complex, costly, and time-consuming endeavor, characterized by high failure rates and significant resource investments. A central bottleneck in early-stage drug discover…

Drug Discovery